These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26190300)

  • 1. Antipsychotic binding to the dopamine-3 receptor in humans: A PET study with [(11)C]-(+)-PHNO.
    Girgis RR; Xu X; Gil RB; Hackett E; Ojeil N; Lieberman JA; Slifstein M; Abi-Dargham A
    Schizophr Res; 2015 Oct; 168(1-2):373-6. PubMed ID: 26190300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing relationships of BMI with BOLD and dopamine D2/3 receptor binding potential in the dorsal striatum.
    Cosgrove KP; Veldhuizen MG; Sandiego CM; Morris ED; Small DM
    Synapse; 2015 Apr; 69(4):195-202. PubMed ID: 25664726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antipsychotics on D3 receptors: a clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO.
    Mizrahi R; Agid O; Borlido C; Suridjan I; Rusjan P; Houle S; Remington G; Wilson AA; Kapur S
    Schizophr Res; 2011 Sep; 131(1-3):63-8. PubMed ID: 21684721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925.
    Graff-Guerrero A; Redden L; Abi-Saab W; Katz DA; Houle S; Barsoum P; Bhathena A; Palaparthy R; Saltarelli MD; Kapur S
    Int J Neuropsychopharmacol; 2010 Apr; 13(3):273-87. PubMed ID: 19751545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional and source-based patterns of [
    Worhunsky PD; Matuskey D; Gallezot JD; Gaiser EC; Nabulsi N; Angarita GA; Calhoun VD; Malison RT; Potenza MN; Carson RE
    Neuroimage; 2017 Mar; 148():343-351. PubMed ID: 28110088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist.
    Searle G; Beaver JD; Comley RA; Bani M; Tziortzi A; Slifstein M; Mugnaini M; Griffante C; Wilson AA; Merlo-Pich E; Houle S; Gunn R; Rabiner EA; Laruelle M
    Biol Psychiatry; 2010 Aug; 68(4):392-9. PubMed ID: 20599188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity and selectivity of [¹¹C]-(+)-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo.
    Gallezot JD; Beaver JD; Gunn RN; Nabulsi N; Weinzimmer D; Singhal T; Slifstein M; Fowles K; Ding YS; Huang Y; Laruelle M; Carson RE; Rabiner EA
    Synapse; 2012 Jun; 66(6):489-500. PubMed ID: 22213512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry.
    Caravaggio F; Scifo E; Sibille EL; Hernandez-Da Mota SE; Gerretsen P; Remington G; Graff-Guerrero A
    Exp Eye Res; 2018 Oct; 175():32-41. PubMed ID: 29883636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography study.
    Nakajima S; Caravaggio F; Boileau I; Chung JK; Plitman E; Gerretsen P; Wilson AA; Houle S; Mamo DC; Graff-Guerrero A
    J Cereb Blood Flow Metab; 2015 Nov; 35(11):1812-8. PubMed ID: 26058690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [
    Slifstein M; Abi-Dargham A; Girgis RR; Suckow RF; Cooper TB; Divgi CR; Sokoloff P; Leriche L; Carberry P; Oya S; Joseph SK; Guiraud M; Montagne A; Brunner V; Gaudoux F; Tonner F
    Psychopharmacology (Berl); 2020 Feb; 237(2):519-527. PubMed ID: 31773210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related changes in binding of the D2/3 receptor radioligand [(11)C](+)PHNO in healthy volunteers.
    Matuskey D; Worhunksy P; Correa E; Pittman B; Gallezot JD; Nabulsi N; Ropchan J; Sreeram V; Gudepu R; Gaiser E; Cosgrove K; Ding YS; Potenza MN; Huang Y; Malison RT; Carson RE
    Neuroimage; 2016 Apr; 130():241-247. PubMed ID: 26876475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [(11)C]-(+)-PHNO.
    Girgis RR; Slifstein M; D'Souza D; Lee Y; Periclou A; Ghahramani P; Laszlovszky I; Durgam S; Adham N; Nabulsi N; Huang Y; Carson RE; Kiss B; Kapás M; Abi-Dargham A; Rakhit A
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3503-12. PubMed ID: 27525990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO.
    Graff-Guerrero A; Mamo D; Shammi CM; Mizrahi R; Marcon H; Barsoum P; Rusjan P; Houle S; Wilson AA; Kapur S
    Arch Gen Psychiatry; 2009 Jun; 66(6):606-15. PubMed ID: 19487625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of scan-time shortening on the
    Matsunaga K; Tonomura M; Abe K; Shimosegawa E
    Ann Nucl Med; 2023 Apr; 37(4):227-237. PubMed ID: 36656501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preliminary study of dopamine D2/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [(11)C](+)PHNO.
    Matuskey D; Gaiser EC; Gallezot JD; Angarita GA; Pittman B; Nabulsi N; Ropchan J; MaCleod P; Cosgrove KP; Ding YS; Potenza MN; Carson RE; Malison RT
    Drug Alcohol Depend; 2015 Sep; 154():167-73. PubMed ID: 26164205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [(11)C]-(+)-PHNO.
    Caravaggio F; Nakajima S; Borlido C; Remington G; Gerretsen P; Wilson A; Houle S; Menon M; Mamo D; Graff-Guerrero A
    Neuropsychopharmacology; 2014 Nov; 39(12):2769-76. PubMed ID: 24874713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Dopamine D3 and D2 Receptor Occupancies by a Single Dose of Blonanserin in Healthy Subjects: A Positron Emission Tomography Study With [11C]-(+)-PHNO.
    Tateno A; Sakayori T; Kim WC; Honjo K; Nakayama H; Arakawa R; Okubo Y
    Int J Neuropsychopharmacol; 2018 Jun; 21(6):522-527. PubMed ID: 29346639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current drug treatments targeting dopamine D3 receptor.
    Leggio GM; Bucolo C; Platania CB; Salomone S; Drago F
    Pharmacol Ther; 2016 Sep; 165():164-77. PubMed ID: 27343365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic doses of buspirone block D3 receptors in the living primate brain.
    Kim SW; Fowler JS; Skolnick P; Muench L; Kang Y; Shea C; Logan J; Kim D; Carter P; King P; Alexoff D; Volkow ND
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1257-67. PubMed ID: 24679922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
    Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
    Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.